345 related articles for article (PubMed ID: 17711447)
21. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
Signoroni S; Frattini M; Negri T; Pastore E; Tamborini E; Casieri P; Orsenigo M; Da Riva L; Radice P; Sala P; Gronchi A; Bertario L; Pierotti MA; Pilotti S
Clin Cancer Res; 2007 Sep; 13(17):5034-40. PubMed ID: 17785554
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
24. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
25. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours.
Soini Y; Vähäkangas K; Nuorva K; Kamel D; Lane DP; Pääkkö P
J Pathol; 1992 Sep; 168(1):29-33. PubMed ID: 1333524
[TBL] [Abstract][Full Text] [Related]
26. Intra-abdominal desmoid fibromatosis mimicking tumour recurrence after the operation: A case series.
Nam KH; Kim B
Malays J Pathol; 2023 Apr; 45(1):111-122. PubMed ID: 37119251
[TBL] [Abstract][Full Text] [Related]
27. Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration.
Owens CL; Sharma R; Ali SZ
Cancer; 2007 Jun; 111(3):166-72. PubMed ID: 17477374
[TBL] [Abstract][Full Text] [Related]
28. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
Le Guellec S; Soubeyran I; Rochaix P; Filleron T; Neuville A; Hostein I; Coindre JM
Mod Pathol; 2012 Dec; 25(12):1551-8. PubMed ID: 22766794
[TBL] [Abstract][Full Text] [Related]
29. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
30. Pediatric aggressive fibromatosis of the head and neck: a 20-year retrospective review.
Sharma A; Ngan BY; Sándor GK; Campisi P; Forte V
J Pediatr Surg; 2008 Sep; 43(9):1596-604. PubMed ID: 18778992
[TBL] [Abstract][Full Text] [Related]
31. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
32. Analysis of TGF-beta protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Stalińska L; Turant M; Sygut J; Tosik D; Dziki A; Kulig A
Pol J Pathol; 2006; 57(2):77-81. PubMed ID: 17019969
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
[TBL] [Abstract][Full Text] [Related]
34. Aspiration biopsy cytology of extraabdominal desmoid tumor concurrently occurring in a patient with tumoral calcinosis.
Saleh H; Kapadia R
Diagn Cytopathol; 2008 Sep; 36(9):624-7. PubMed ID: 18677759
[TBL] [Abstract][Full Text] [Related]
35. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
[TBL] [Abstract][Full Text] [Related]
36. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.
Montgomery E; Torbenson MS; Kaushal M; Fisher C; Abraham SC
Am J Surg Pathol; 2002 Oct; 26(10):1296-301. PubMed ID: 12360044
[TBL] [Abstract][Full Text] [Related]
37. Differential diagnostic considerations of desmoid-type fibromatosis.
Goldstein JA; Cates JM
Adv Anat Pathol; 2015 Jul; 22(4):260-6. PubMed ID: 26050263
[TBL] [Abstract][Full Text] [Related]
38. Isolated desmoid tumor of pancreatic tail with cyst formation diagnosed by beta-catenin immunostaining: a rare case report with review of literature.
Rao RN; Agarwal P; Rai P; Kumar B
JOP; 2013 May; 14(3):296-301. PubMed ID: 23669485
[TBL] [Abstract][Full Text] [Related]
39. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
Torres JC; Xin C
J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
[TBL] [Abstract][Full Text] [Related]
40. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
Ferenc T; Sygut J; Kopczyński J; Mayer M; Latos-Bieleńska A; Dziki A; Kulig A
Pol J Pathol; 2006; 57(1):5-15. PubMed ID: 16739877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]